61 results
Page 2 of 4
6-K
EX-99.1
t1n5lkqw
10 Jun 22
Current report (foreign)
6:05am
F-3/A
7xzcqix5p5pp
20 May 22
Shelf registration (foreign) (amended)
6:54pm
6-K
ngv3s l29g204x
3 May 22
Connect Biopharma Announces Week 12 Top-Line Results from Phase 2 CBP-307 Trial in Patients with Moderate-to-Severe Ulcerative Colitis
4:36pm
6-K
EX-99.2
7d0q5gsfzj 3lgb
3 May 22
Connect Biopharma Announces Week 12 Top-Line Results from Phase 2 CBP-307 Trial in Patients with Moderate-to-Severe Ulcerative Colitis
4:36pm
6-K
EX-99.1
bv6n0mg
3 May 22
Connect Biopharma Announces Week 12 Top-Line Results from Phase 2 CBP-307 Trial in Patients with Moderate-to-Severe Ulcerative Colitis
4:36pm
F-3
w3bp4ox3eif29
15 Apr 22
Shelf registration (foreign)
5:27pm
6-K
EX-99.1
hziu80zj16mw9jf l2
31 Mar 22
Connect Biopharma Reports Full Year 2021 Financial Results
5:15pm
20-F
afw9ntzbqu2t6969v
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-4.11
qwsqg qttjhkge0
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-4.12
lvh0tvomzbx7tc4b
31 Mar 22
Annual report (foreign)
4:33pm
6-K
EX-99.1
dwg7mg
16 Feb 22
Current report (foreign)
4:01pm
6-K
hpvzp6uty6ggt4v1
5 Jan 22
Current report (foreign)
5:24pm
6-K
EX-99.2
pns29fuz8b2
5 Jan 22
Current report (foreign)
5:24pm
6-K
EX-99.1
yvvd7 53gx
5 Jan 22
Current report (foreign)
5:24pm
6-K
EX-99.1
mknw4lbr3yr1iz0v6d6
19 Nov 21
Connect Biopharma Completes Enrollment of CBP-307 Global Phase 2 Clinical Trial in Moderate-to-Severe Ulcerative Colitis
4:01pm
6-K
EX-99.1
o2jychp 36re1ay1
19 Nov 21
Primary endpoint met with all three CBP-201 arms achieving significant improvements
8:00am
6-K
c2upssje
19 Nov 21
Primary endpoint met with all three CBP-201 arms achieving significant improvements
8:00am
6-K
EX-99.1
j8oajvgqh7i
8 Sep 21
Connect Biopharma Announces First Subject Dosed in Phase 2 Trial Evaluating
8:31am
6-K
EX-99.1
6yrh5f kv6
2 Sep 21
Connect Biopharma Announces First Patient Dosed in China Pivotal Trial
4:40pm
6-K
EX-99.3
su1ujhuk
31 Aug 21
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:16pm